P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS

ABSTRACT:

SUBMITTER: Dinardo C 

PROVIDER: S-EPMC10428933 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature